Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

IDMC reviews Ziopharm's study of palifosfamide in metastatic soft tissue sarcoma

Jan. 30, 2012

Cell Therapeutics withdraws Pixuvri NDA

Jan. 30, 2012

FDA approves axitinib for advanced renal cell carcinoma

Jan. 30, 2012

Infinity Pharmaceuticals completes preliminary analysis of saridegib/gemcitabine combination study

Jan. 30, 2012

FDA accepts bosutinib NDA for review

Jan. 30, 2012

Cancer Research UK begins study of AT-9283

Jan. 30, 2012

Scientists at Cellzome patent novel TYK2 inhibitors

Jan. 30, 2012

Merck KGaA patents new TGF-beta receptor type-1 inhibitors

Jan. 30, 2012

Pierre Fabre discloses new monoclonal antibodies for cancer

Jan. 30, 2012

Enrollment begins in Japan in phase III trials of orteronel

Jan. 27, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...